In contrast to the cAMP-Sirt6 pathway’s suppression of radiation-induced NSCLC cell death [122], the cAMP–PKA–CREB pathway seems to have an anticancer effect in radiotherapy. This evidence concerns the gene CREB1 and non-small cell lung carcinoma.